InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Mccormick Frank. Director active across 1 company, notably BridgeBio Pharma, Inc.. Cumulatively, 10 disclosures have been recorded. Split: 0 buy · 4 sells. Total volume traded: €14m. Activity tracked since 26 December 2023. The latest transaction was filed on 29 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
MCCORMICK FRANK is a Director at BridgeBio Pharma, Inc. The declarant has 10 filings in total, and across the 10 sampled filings the transactions are sales, with EUR 0 of buys and EUR 13,993,769 of sells between 2023-12-28 and 2026-06-24.